US Patent Issued to University of Southern California on March 17 for "Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer" (California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,281, issued on March 17, was assigned to University of Southern California (Los Angeles).

"Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer" was invented by Pinchas Cohen (Los Angeles), Kelvin Yen (Los Angeles) and Su-Jeong Kim (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein is a new mitochondrial peptide. This small peptide is capable of modulating cancer, through a variety of mechanisms including autophagy/apoptosis, reduction of tumor cell viability, inducing inflammatory response in senescent cells and conversion of macrophage cell type. Administration...